A single-dose adenovirus-vectored rabies vaccine (ChAdOx2 RabG) was safe and produced strong antibody responses in Tanzanian adults and children. After 1 year, antibody levels remained above the protection threshold and exceeded those from licensed rabies vaccines
Read Full Article
#RabiesVaccine #ChAdOx2 #GlobalHealth
Read Full Article
#RabiesVaccine #ChAdOx2 #GlobalHealth
The Lancet Infectious Diseases
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim…
The ChAdOx2 RabG vaccine was safe and well tolerated in Tanzanian adults and children.
It achieved robust attainment and maintenance of VNA responses, with titres at day
365 exceeding the correlate of protection (VNA ≥0·5 IU/mL) and titres in licensed
vaccine…
It achieved robust attainment and maintenance of VNA responses, with titres at day
365 exceeding the correlate of protection (VNA ≥0·5 IU/mL) and titres in licensed
vaccine…